Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03181256 · ClinicalTrials.gov registry record

Early Detection of Lung Cancer

A clinical trial of Lung Cancer, sponsored by Vanderbilt-Ingram Cancer Center.

Active
Registry status
45
Enrollment target
1
Study location

NCT03181256 is a study of Lung Cancer that is active but no longer recruiting, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 45 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03181256, a study of Lung Cancer, is active but no longer recruiting, sponsored by Vanderbilt-Ingram Cancer Center.

ACTIVE NOT RECRUITING
Registry status
45 participants
Enrollment target
1
Study location

Study Summary

This research trial studies the long term follow-up for early detection of lung cancer in current or former smokers. Following up on smokers by collecting and analyzing specimens in the laboratory, performing chest computed tomography (CT) scans, as well as reviewing medical records may help doctors detect lung cancer at an earlier stage.

Conditions Studied

Interventions

  • PROCEDURE Biospecimen Collection
  • PROCEDURE Biospecimen collection

Study Locations (1)

Tennessee

  • Vanderbilt-Ingram Cancer Center - Nashville

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2017-12-14
Est. Completion 2025-12-01

Sponsor

Vanderbilt-Ingram Cancer Center

189 total trials

What the Registry Record Tells You About NCT03181256

The ClinicalTrials.gov registry entry for NCT03181256 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Biospecimen Collection is the first listed.

NCT03181256 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03181256 about?

NCT03181256 is a clinical study titled "Early Detection of Lung Cancer". This research trial studies the long term follow-up for early detection of lung cancer in current or former smokers. Following up on smokers by collecting and analyzing specimens in the laboratory, performing chest computed tomography (CT) scans, as well as reviewing medical records may help doctors...

What is the current status of trial NCT03181256?

This trial is currently active not recruiting. The enrollment target is 45 participants. The study started on 2017-12-14. Estimated completion is 2025-12-01.

What conditions does trial NCT03181256 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT03181256?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Biospecimen collection (PROCEDURE).

Who is sponsoring clinical trial NCT03181256?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03181256 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.